16-173259-T-C

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM1PP3

The NM_000517.6(HBA2):​c.230T>C​(p.Met77Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000542 in 1,476,148 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M77I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000029 ( 0 hom., cov: 22)
Exomes 𝑓: 0.0000030 ( 0 hom. )

Consequence

HBA2
NM_000517.6 missense

Scores

6
5
5

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.72

Publications

0 publications found
Variant links:
Genes affected
HBA2 (HGNC:4824): (hemoglobin subunit alpha 2) The human alpha globin gene cluster located on chromosome 16 spans about 30 kb and includes seven loci: 5'- zeta - pseudozeta - mu - pseudoalpha-1 - alpha-2 - alpha-1 - theta - 3'. The alpha-2 (HBA2) and alpha-1 (HBA1) coding sequences are identical. These genes differ slightly over the 5' untranslated regions and the introns, but they differ significantly over the 3' untranslated regions. Two alpha chains plus two beta chains constitute HbA, which in normal adult life comprises about 97% of the total hemoglobin; alpha chains combine with delta chains to constitute HbA-2, which with HbF (fetal hemoglobin) makes up the remaining 3% of adult hemoglobin. Alpha thalassemias result from deletions of each of the alpha genes as well as deletions of both HBA2 and HBA1; some nondeletion alpha thalassemias have also been reported. [provided by RefSeq, Jul 2008]
HBA2 Gene-Disease associations (from GenCC):
  • alpha thalassemia spectrum
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
  • erythrocytosis, familial, 7
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • hemoglobin M disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hb Bart's hydrops fetalis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hemoglobin H disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Heinz body anemia
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • methemoglobinemia, alpha type
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 7 benign, 12 uncertain in NM_000517.6
PP3
MetaRNN computational evidence supports a deleterious effect, 0.786

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HBA2NM_000517.6 linkc.230T>C p.Met77Thr missense_variant Exon 2 of 3 ENST00000251595.11 NP_000508.1 P69905D1MGQ2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HBA2ENST00000251595.11 linkc.230T>C p.Met77Thr missense_variant Exon 2 of 3 1 NM_000517.6 ENSP00000251595.6 P69905

Frequencies

GnomAD3 genomes
AF:
0.0000294
AC:
4
AN:
136076
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0000970
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000705
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
141584
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000298
AC:
4
AN:
1340072
Hom.:
0
Cov.:
25
AF XY:
0.00000301
AC XY:
2
AN XY:
665250
show subpopulations
African (AFR)
AF:
0.0000378
AC:
1
AN:
26426
American (AMR)
AF:
0.0000265
AC:
1
AN:
37744
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24818
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36604
South Asian (SAS)
AF:
0.00
AC:
0
AN:
77864
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35392
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3884
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1041482
Other (OTH)
AF:
0.0000358
AC:
2
AN:
55858
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0000294
AC:
4
AN:
136076
Hom.:
0
Cov.:
22
AF XY:
0.0000304
AC XY:
2
AN XY:
65870
show subpopulations
African (AFR)
AF:
0.0000970
AC:
3
AN:
30930
American (AMR)
AF:
0.0000705
AC:
1
AN:
14190
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3320
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4718
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4044
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10052
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
306
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
65790
Other (OTH)
AF:
0.00
AC:
0
AN:
1838
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.588
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000416

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Feb 23, 2023
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.230T>C (p. Met77Thr) variant (Hb Aztec) is reported with normal clinical presentation in heterozygous state and associated with normal function. The frequency of this variant in the general population, 0.000006 (1/167268 chromosomes, http://gnomad.broadinstitute.org), is uninformative in assessment of its pathogenicity. In the published literature, the variant has been reported in a female infant and her mother, with normal hematological indices (PMID: 3935608 (1985)). Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded conflicting predictions that this variant is deleterious or benign. Based on the available information, we are unable to determine the clinical significance of this variant. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.18
D
BayesDel_noAF
Uncertain
0.020
CADD
Benign
21
DANN
Benign
0.74
DEOGEN2
Benign
0.015
.;T
Eigen
Benign
-0.23
Eigen_PC
Benign
-0.22
FATHMM_MKL
Pathogenic
0.98
D
M_CAP
Pathogenic
0.44
D
MetaRNN
Pathogenic
0.79
D;D
MetaSVM
Uncertain
0.29
D
PhyloP100
5.7
PrimateAI
Uncertain
0.64
T
PROVEAN
Uncertain
-2.9
D;D
REVEL
Uncertain
0.52
Sift
Pathogenic
0.0
D;D
Sift4G
Pathogenic
0.0010
D;D
Vest4
0.48
MutPred
0.58
Loss of stability (P = 0.0543);.;
MVP
0.99
MPC
1.7
ClinPred
0.87
D
GERP RS
4.2
PromoterAI
-0.037
Neutral
gMVP
0.83
Mutation Taster
=48/52
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs281864860; hg19: chr16-223258; API